10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $56,546,000 | -70.5% | 1,249,646 | -50.4% | 4.82% | -58.6% |
Q1 2022 | $191,582,000 | -35.8% | 2,518,500 | +25.7% | 11.65% | -12.1% |
Q4 2021 | $298,516,000 | +6.7% | 2,004,000 | +4.3% | 13.24% | +3.8% |
Q3 2021 | $279,805,000 | -25.7% | 1,922,000 | 0.0% | 12.76% | -19.1% |
Q2 2021 | $376,366,000 | +8.2% | 1,922,000 | 0.0% | 15.78% | -4.8% |
Q1 2021 | $347,882,000 | +27.8% | 1,922,000 | 0.0% | 16.58% | +41.8% |
Q4 2020 | $272,155,000 | +13.6% | 1,922,000 | 0.0% | 11.69% | +0.3% |
Q3 2020 | $239,635,000 | +87.0% | 1,922,000 | +33.9% | 11.66% | +76.1% |
Q2 2020 | $128,160,000 | – | 1,435,000 | – | 6.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |